Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.55 Million INR | 53.32% |
| 2022 | 2.97 Million INR | -29.63% |
| 2021 | 4.22 Million INR | 47.72% |
| 2020 | 2.85 Million INR | -15.14% |
| 2019 | 3.36 Million INR | 37.49% |
| 2018 | 2.44 Million INR | 69.14% |
| 2017 | 1.44 Million INR | -50.07% |
| 2016 | 2.9 Million INR | 377.29% |
| 2015 | 607.75 Thousand INR | 15.57% |
| 2014 | 525.86 Thousand INR | -1.65% |
| 2013 | 534.68 Thousand INR | -96.66% |
| 2012 | 15.98 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 401 Thousand INR | -73.72% |
| 2024 Q1 | 1.52 Million INR | 53.99% |
| 2023 Q4 | 991 Thousand INR | -19.82% |
| 2023 Q2 | 514 Thousand INR | -44.67% |
| 2023 Q3 | 1.23 Million INR | 140.47% |
| 2023 FY | 3.61 Million INR | 21.54% |
| 2023 Q1 | 929 Thousand INR | -27.87% |
| 2022 Q4 | 1.28 Million INR | 263.84% |
| 2022 Q2 | 1.44 Million INR | 109.86% |
| 2022 FY | 2.97 Million INR | -29.63% |
| 2022 Q1 | 690 Thousand INR | -74.69% |
| 2022 Q3 | 354 Thousand INR | -75.55% |
| 2021 Q4 | 2.72 Million INR | 106.99% |
| 2021 Q1 | 915 Thousand INR | -40.85% |
| 2021 Q3 | 1.31 Million INR | 254.99% |
| 2021 FY | 4.22 Million INR | 47.72% |
| 2021 Q2 | 371 Thousand INR | -59.45% |
| 2020 Q4 | 1.54 Million INR | 412.25% |
| 2020 FY | 2.85 Million INR | -15.14% |
| 2020 Q1 | 1.9 Million INR | -21.72% |
| 2020 Q2 | 2.22 Million INR | 16.69% |
| 2020 Q3 | 302 Thousand INR | -86.41% |
| 2019 Q4 | 2.43 Million INR | 59.27% |
| 2019 FY | 3.36 Million INR | 37.49% |
| 2019 Q3 | 1.52 Million INR | 65.73% |
| 2019 Q2 | 922 Thousand INR | -5.53% |
| 2019 Q1 | 975.99 Thousand INR | -9.51% |
| 2018 Q3 | 890 Thousand INR | 17.26% |
| 2018 Q4 | 1.07 Million INR | 21.19% |
| 2018 Q2 | 759 Thousand INR | 47.95% |
| 2018 FY | 2.44 Million INR | 69.14% |
| 2018 Q1 | 512.99 Thousand INR | -0.88% |
| 2017 FY | 1.44 Million INR | -50.07% |
| 2017 Q3 | 209.99 Thousand INR | -13.93% |
| 2017 Q4 | 517.56 Thousand INR | 146.46% |
| 2017 Q1 | 2.25 Million INR | 133.32% |
| 2017 Q2 | 244 Thousand INR | -89.19% |
| 2016 Q1 | 1.43 Million INR | 1050.28% |
| 2016 Q3 | 2.61 Million INR | 48.97% |
| 2016 Q2 | 1.75 Million INR | 22.11% |
| 2016 Q4 | 967.77 Thousand INR | -63.01% |
| 2016 FY | 2.9 Million INR | 377.29% |
| 2015 Q2 | 91 Thousand INR | -68.62% |
| 2015 Q4 | 125.01 Thousand INR | 27.56% |
| 2015 FY | 607.75 Thousand INR | 15.57% |
| 2015 Q1 | 290 Thousand INR | 96.12% |
| 2015 Q3 | 98 Thousand INR | 7.69% |
| 2014 Q1 | 135 Thousand INR | -60.02% |
| 2014 Q3 | 41 Thousand INR | -79.6% |
| 2014 Q2 | 201 Thousand INR | 48.89% |
| 2014 FY | 525.86 Thousand INR | -1.65% |
| 2014 Q4 | 147.86 Thousand INR | 260.65% |
| 2013 Q3 | 33 Thousand INR | 10.0% |
| 2013 Q2 | 30 Thousand INR | -77.44% |
| 2013 Q1 | 133 Thousand INR | -97.22% |
| 2013 Q4 | 337.68 Thousand INR | 923.28% |
| 2013 FY | 534.68 Thousand INR | -96.66% |
| 2012 FY | 15.98 Million INR | 0.0% |
| 2012 Q4 | 4.78 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 2.6 Million INR | -74.625% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 96.954% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | 62.969% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 96.87% |
| Sunil Healthcare Limited | 438.1 Million INR | 98.96% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -133.95% |
| MedPlus Health Services Limited | 2.42 Billion INR | 99.812% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 97.526% |
| Patidar Buildcon Limited | 1.81 Million INR | -151.518% |
| Roopa Industries Limited | 24.63 Million INR | 81.51% |
| Smruthi Organics Limited | 261.73 Million INR | 98.26% |
| Trident Lifeline Limited | 46.87 Million INR | 90.282% |
| PANJON LTD. | 33.77 Million INR | 86.515% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | 94.045% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 96.56% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -4157.009% |
| Anuh Pharma Limited | 263.04 Million INR | 98.268% |
| Crestchem Limited | 50.8 Million INR | 91.034% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -5.391% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 97.861% |
| Tyche Industries Limited | 182.04 Million INR | 97.498% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 98.736% |
| Trimurthi Limited | 4.81 Million INR | 5.321% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | 94.516% |
| Norris Medicines Limited | 18.2 Million INR | 74.98% |
| Zenlabs Ethica Limited | 57.89 Million INR | 92.132% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 95.632% |
| ANG Lifesciences India Limited | 219.92 Million INR | 97.929% |
| Parmax Pharma Limited | 99.31 Million INR | 95.414% |
| Veerhealth Care Limited | 15.38 Million INR | 70.387% |
| Deccan Health Care Limited | 36.24 Million INR | 87.432% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 96.882% |
| Makers Laboratories Limited | 83.1 Million INR | 94.519% |
| Lactose (India) Limited | 111.66 Million INR | 95.921% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | 80.845% |
| Zenith Healthcare Limited | 45.97 Million INR | 90.093% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 97.819% |
| Bacil Pharma Limited | 1.87 Million INR | -143.012% |
| PRAVEG LIMITED | 77.18 Million INR | 94.098% |
| Denis Chem Lab Limited | 453.36 Million INR | 98.995% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 98.17% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 98.958% |
| Colinz Laboratories Limited | 31.19 Million INR | 85.4% |
| Godavari Drugs Limited | 359.01 Million INR | 98.731% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -198.885% |
| Zenotech Laboratories Limited | 94.82 Million INR | 95.196% |
| Panchsheel Organics Limited | 68.15 Million INR | 93.317% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 95.626% |
| Phaarmasia Limited | 50.52 Million INR | 90.985% |
| Sastasundar Ventures Limited | 846.78 Million INR | 99.462% |
| Medi-Caps Limited | 93.11 Million INR | 95.108% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 98.359% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 97.096% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 98.378% |
| Mercury Laboratories Limited | 217.24 Million INR | 97.903% |
| Gennex Laboratories Limited | 130.37 Million INR | 96.506% |
| BDH Industries Limited | 57.03 Million INR | 92.013% |
| Coral Laboratories Limited | 189.75 Million INR | 97.6% |
| Concord Drugs Limited | 91.83 Million INR | 95.04% |
| Bharat Parenterals Limited | 255.97 Million INR | 98.221% |
| Beryl Drugs Limited | 93.77 Million INR | 95.142% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | 77.412% |
| Evoq Remedies Limited | 4.51 Million INR | -0.841% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 96.891% |
| Transchem Limited | 8.47 Million INR | 46.241% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | 72.339% |
| Parnax Lab Limited | 80.59 Million INR | 94.348% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | 85.702% |
| Kerala Ayurveda Limited | 399.64 Million INR | 98.86% |
| Cian Healthcare Limited | 59.19 Million INR | 92.306% |
| Trinity League India Limited | -1.08 Million INR | 519.429% |
| Syschem (India) Limited | 64.13 Million INR | 92.897% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -83.669% |
| Natural Capsules Limited | 444.7 Million INR | 98.976% |
| Auro Laboratories Limited | 157.37 Million INR | 97.106% |